Učitavanje...
The KDM1A histone demethylase is a promising new target for the epigenetic therapy of medulloblastoma
BACKGROUND: Medulloblastoma is a leading cause of childhood cancer-related deaths. Current aggressive treatments frequently lead to cognitive and neurological disabilities in survivors. Novel targeted therapies are required to improve outcome in high-risk medulloblastoma patients and quality of life...
Spremljeno u:
| Glavni autori: | , , , , , , , , , , , , , |
|---|---|
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
BioMed Central
2013
|
| Teme: | |
| Online pristup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3893444/ https://ncbi.nlm.nih.gov/pubmed/24252778 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/2051-5960-1-19 |
| Oznake: |
Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|